Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mod Resources Limited | LSE:MOD | London | Ordinary Share | AU000000MOD3 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 22.50 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Mar 2020 to Mar 2025
TIDMMOD
RNS Number : 6285P
MOD Resources Limited
11 October 2019
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity MOD Resources Limited ABN 78 003 103 544
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
Hot Features
Premium
1 +Class of +securities issued (i) Fully Paid Ordinary Shares
or to be issued (ii) Fully Paid Ordinary Shares
(iii) Fully Paid Ordinary Shares
2 Number of +securities issued (i) 2,875,000 Fully Paid Ordinary Shares
or to be issued (if known) (ii) 22,322,222 Fully Paid Ordinary
or maximum number which may Shares
be issued (iii) 4,825,168 Fully Paid Ordinary
Shares
3 Principal terms of the +securities (i) Fully Paid Ordinary Shares
(e.g. if options, exercise (ii) Fully Paid Ordinary Shares
price and expiry date; if (iii) Fully Paid Ordinary Shares
partly paid +securities,
the amount outstanding and
due dates for payment; if
+convertible securities,
the conversion price and
dates for conversion)
4 Do the +securities rank equally (i) Yes, the shares will rank equally
in all respects from the with ordinary shares currently on
+issue date with an existing issue.
+class of quoted +securities? (ii) Yes, the shares will rank equally
with ordinary shares currently on
If the additional +securities issue.
do not rank equally, please (iii) Yes, the shares will rank
state: equally with ordinary shares currently
* the date from which they do on issue.
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution)
or
interest payment
* the extent to which they do not rank equally, oth
er
than in relation to the next dividend, distributi
on
or interest payment
5 Issue price or consideration (i) Nil
(ii) Nil
(iii) Nil
Purpose of the issue (i) Issue of shares following exercise
(If issued as consideration of vested Performance Rights.
6 for the acquisition of assets, (ii) Issue of shares pursuant to
clearly identify those assets) the JV Consolidation Option exercised
on 10 October 2019 and approved
by shareholders at the General Meeting
held 1 October 2019.
(iii) Issue of shares following
exercise of Consideration Options
following Court approval of the
Scheme and as approved by shareholders
at the General Meeting held 1 October
2019.
Is the entity an +eligible Yes
entity that has obtained
6a security holder approval
under rule 7.1A?
If Yes, complete sections
6b - 6h in relation to the
+securities the subject of
this Appendix 3B, and comply
with section 6i
The date the security holder 29 May 2019
resolution under rule 7.1A
6b was passed
Number of +securities issued N/A
without security holder approval
6c under rule 7.1
Number of +securities issued N/A
with security holder approval
6d under rule 7.1A
Number of +securities issued (i) 2,875,000 Fully Paid Ordinary
with security holder approval Shares following the exercise of
6e under rule 7.3, or another vested Performance Rights in accordance
specific security holder approval with the Company's Performance Rights
(specify date of meeting) Plan approved at the General Meeting
held 20 February 2017.
(ii) 22,322,222 Fully Paid Ordinary
Shares following approval by shareholders
at the General Meeting held 1 October
2019.
(iii) 4,825,168 Fully Paid Ordinary
Shares following exercise of Consideration
Options following Court approval
of the Scheme and as approved by
shareholders at the General Meeting
held 1 October 2019.
Number of +securities issued N/A
under an exception in rule
6f 7.2
If +securities issued under N/A
rule 7.1A, was issue price
6g at least 75% of 15-day VWAP
as calculated under rule 7.1A.3?
Include the +issue date and
both values. Include the source
of the VWAP calculation.
If +securities were issued N/A
under rule 7.1A for non-cash
6h consideration, state date
on which valuation of consideration
was released to ASX Market
Announcements
Calculate the entity's remaining Refer Annexure 1
issue capacity under rule
6i 7.1 and rule 7.1A - complete
Annexure 1 and release to
ASX Market Announcements
7 +Issue dates 11 October 2019
Note: The issue date may be
prescribed by ASX (refer to
the definition of issue date
in rule 19.12). For example,
the issue date for a pro rata
entitlement issue must comply
with the applicable timetable
in Appendix 7A.
Cross reference: item 33 of
Appendix 3B.
Number +Class
Number and +class of all
+securities quoted on ASX Fully Paid
(including the +securities Ordinary
8 in section 2 if applicable) 370,157,018 shares
-------------------------
Unlisted
options
exercisable
at $0.457
on or
before 30
January
2023,
vesting
12 months
from the
date of
issue and
subject to
a
restriction
period to
30 January
2022;
Unlisted
options
exercisable
at $0.707
on or
before 30
January
2023
vesting
24 months
from the
date of
issue and
subject to
a
restriction
period to
30 January
2022;
Unlisted
options
exercisable
at $0.907
on or
before 30
January
2023
vesting
36 months
from the
date of
issue and
subject to
a
restriction
period to
30 January
2022;
Performance
Rights
vesting in
various
tranches
expiring
21 February
2022;
3,015,000 Unlisted
options
exercisable
at $0.522
on or
before 12
April 2023
vesting
3,015,000 36 months
from the
date of
issue and
subject to
a
restriction
period to
3,015,000 12 April
2022;
Unlisted
options
exercisable
at $0.435
on or
3,050,000 before 29
May 2023
vesting
36 months
5,030,000 from the
date of
issue and
subject to
a
Number and +class of all restriction
+securities not quoted on period to
ASX (including the +securities 29 May
9 in section 2 if applicable) 3,630,000 2022;
-------------------------
10 Dividend policy (in the The Company does not have a dividend
case of a trust, distribution policy.
policy) on the increased
capital (interests)
Part 2 -- Pro rata issue
11 Is security holder approval N/A
required?
12 Is the issue renounceable N/A
or non-renounceable?
13 Ratio in which the +securities N/A
will be offered
14 +Class of +securities to N/A
which the offer relates
15 +Record date to determine N/A
entitlements
16 Will holdings on different N/A
registers (or subregisters)
be aggregated for calculating
entitlements?
17 Policy for deciding entitlements N/A
in relation to fractions
18 Names of countries in which N/A
the entity has security holders
who will not be sent new
offer documents
Note: Security holders must
be told how their entitlements
are to be dealt with.
Cross reference: rule 7.7.
19 Closing date for receipt N/A
of acceptances or renunciations
20 Names of any underwriters N/A
21 Amount of any underwriting fee N/A
or commission
22 Names of any brokers to the N/A
issue
23 Fee or commission payable to N/A
the broker to the issue
24 Amount of any handling fee payable N/A
to brokers who lodge acceptances
or renunciations on behalf of
security holders
25 If the issue is contingent on N/A
security holders' approval,
the date of the meeting
26 Date entitlement and acceptance N/A
form and offer documents will
be sent to persons entitled
27 If the entity has issued options, N/A
and the terms entitle option
holders to participate on exercise,
the date on which notices will
be sent to option holders
28 Date rights trading will begin N/A
(if applicable)
29 Date rights trading will end N/A
(if applicable)
30 How do security holders sell N/A
their entitlements in full
through a broker?
31 How do security holders sell N/A
part of their entitlements
through a broker and accept
for the balance?
32 How do security holders dispose N/A
of their entitlements (except
by sale through a broker)?
33 +Issue date N/A
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities
(tick one)
(a) +Securities described in Part 1
(b) All other +securities
Example: restricted securities at the end of the
escrowed period, partly paid securities that become
fully paid, employee incentive share securities
when restriction ends, securities issued on expiry
or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing
the information or documents
35 If the +securities are +equity securities, the
names of the 20 largest holders of the additional
+securities, and the number and percentage of
additional +securities held by those holders
36 If the +securities are +equity securities, a distribution
schedule of the additional +securities setting
out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of +securities N/A
for which +quotation
is sought
39 +Class of +securities N/A
for which quotation
is sought
40 Do the +securities N/A
rank equally in all
respects from the +issue
date with an existing
+class of quoted +securities?
If the additional +securities
do not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
41 Reason for request N/A
for quotation now
Example: In the case
of restricted securities,
end of restriction
period
(if issued upon conversion
of another +security,
clearly identify that
other +security)
Number +Class
42 Number and +class of all N/A
+securities quoted on ASX
(including the +securities
in clause 38)
----------------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the (+) securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
MARK CLEMENTS
Company Secretary
11 October 2019
== == == == ==
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Insert number of fully paid +ordinary
securities on issue 12 months
before the +issue date or date
of agreement to issue 264,815,953
--------------------------
Add the following:
* Number of fully paid +ordinary securities issued in
that 12-month period under an exception in rule 7.2
* Number of fully paid +ordinary securities issued in
that 12-month period with shareholder approval
(i) 16 November 2018 Issue of
Shares
(ii) 30 January 2019 Issue of
Shares
(iii) 27 February 2019 Issue
of Shares pursuant to non-renounceable
entitlement offer
(iv) 12 April 2019 Issue of Shares
(v) 12 April 2019 Issue of Shares
following exercise of options
(vi) 26 June 2019 Issue of Shares
(vii) 26 June 2019 Issue of Shares
(viii) 18 July 2019 Issue of
Shares
(ix) 13 September 2019 Issue
of Shares following exercise
of Options
(x) 11 October 2019 Issue of
Shares following vesting Performance
Rights
(xi) 11 October 2019 Issue of
Shares
(xii) 11 October 2019 Issue of
Shares following exercise of
Options 17,090,000
423,069
* Number of partly paid +ordinary securities that 21,353,317
became fully paid in that 12-month period
Note: 53,971
* Include only ordinary securities here - other classes 766
of equity securities cannot be added
194,428
67,539
* Include here (if applicable) the securities the 287,187
subject of the Appendix 3B to which this form is 35,848,398
annexed
2,875,000
* It may be useful to set out issues of securities on 22,322,222
different dates as separate line items 4,825,168
--------------------------
Subtract the number of fully Nil
paid +ordinary securities cancelled
during that 12-month period
--------------------------
"A" 370,157,018
--------------------------
Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be
changed]
----------------------------------------
Multiply "A" by 0.15 55,523,553
----------------------------------------
Step 3: Calculate "C", the amount of placement capacity under
rule 7.1 that has already been used
Insert number of +equity securities
issued or agreed to be issued
in that 12-month period not counting
those issued:
* Under an exception in rule 7.2
* Under rule 7.1A
* With security holder approval under rule 7.1 or rule
7.4
Note:
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
----------------------------------------
"C" -
----------------------------------------
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
"A" x 0.15
Note: number must be same as
shown in Step 2 55,523,553
----------------------------------------
Subtract "C" -
Note: number must be same as
shown in Step 3
----------------------------------------
Total ["A" x 0.15] - "C" 55,523,553
[Note: this is the
remaining
placement capacity under
rule
7.1]
----------------------------------------
Part 2
Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"A"
Note: number must be same as shown
in Step 1 of Part 1 370,157,018
--------------------------------------
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot
be changed
--------------------------------------
Multiply "A" by 0.10 37,015,702
--------------------------------------
Step 3: Calculate "E", the amount of placement capacity under
rule 7.1A that has already been used
Insert number of +equity securities
issued or agreed to be issued in
that 12-month period under rule
7.1A
Notes:
* This applies to equity securities - not just ordinary
securities
* Include here - if applicable - the securities the
subject of the Appendix 3B to which this form is
annexed
* Do not include equity securities issued under rule
7.1 (they must be dealt with in Part 1), or for which
specific security holder approval has been obtained
* It may be useful to set out issues of securities on
different dates as separate line items
--------------------------------------
"E" -
--------------------------------------
Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A
"A" x 0.10
Note: number must be same as shown
in Step 2 37,015,702
------------------------------------------
Subtract "E" -
Note: number must be same as shown
in Step 3
------------------------------------------
Total ["A" x 0.10] - "E" 37,015,702
Note: this is the remaining
placement capacity under
rule 7.1A
------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCGGGWCUUPBUBG
(END) Dow Jones Newswires
October 11, 2019 05:47 ET (09:47 GMT)
1 Year Mod Resources Chart |
1 Month Mod Resources Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
